Molecular genetic studies on the biosynthesis of aldosterone in humans

J Steroid Biochem Mol Biol. 1992 Dec;43(8):981-7. doi: 10.1016/0960-0760(92)90326-E.

Abstract

Corticosterone methyl oxidase Type I (CMO I) and II (CMO II) have been postulated to be the enzymes involved in the final two steps of aldosterone biosynthesis in humans. We have isolated human cDNAs for P450c11 and P450c18 as well as the corresponding genes, CYP11B1 and CYP11B2. Both protein products of these two genes as expressed in COS-7 cells exhibit steroid 11β-hydroxylase activity, but only P450c18, a product of CYP11B2, carried steroid 18-hydroxylase activity to form aldosterone. These results indicate that CYP11B2 encodes CMO, the actual catalytic function of which is retained by P450c18, a multifunctional enzyme. This conclusion is further supported by the finding that the P450c18 gene, CYP11B2, is mutated at several different loci in patients deficient in CMO I or II.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex / enzymology*
  • Adrenal Cortex / metabolism
  • Aldosterone / metabolism*
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Biocatalysis
  • COS Cells
  • Chlorocebus aethiops
  • Cytochrome P-450 CYP11B2 / chemistry
  • Cytochrome P-450 CYP11B2 / deficiency
  • Cytochrome P-450 CYP11B2 / genetics
  • Cytochrome P-450 CYP11B2 / metabolism*
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Mutant Proteins / chemistry
  • Mutant Proteins / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism

Substances

  • Mutant Proteins
  • Recombinant Proteins
  • Aldosterone
  • Cytochrome P-450 CYP11B2
  • corticosterone methyl oxidase I
  • corticosterone methyl oxidase II